Nestle Corporation
Independent Assurance Statement by Bureau Veritas
Introduction
Bureau Veritas has been commissioned by Nestlé S.A. to provide independent assurance of Nestlé
Philippines compliance with the World Health Organisation (WHO) International Code of Marketing of
Breast Milk Substitutes (1981) and subsequent World Health Assembly (WHA) resolutions (herein known as the WHO Code) and the Philippines Executive Order No. 51 1986, National Code of
Marketing of Breastmilk Substitutes, Breastmilk Supplements and other related products (herein known as EO51), and the Revised Implementing Rules and Regulations 2006 (herein known as
RIRR). This follows similar work previously conducted by Bureau Veritas for Nestlé SA in other global operations. Scope of Work and Methodology
The assurance was conducted in the Philippines between 11 and 22 October 2010 by two assessors from Bureau Veritas UK Limited. The team has extensive experience of undertaking WHO Code compliance related work and was supported by two representatives of Bureau Veritas Philippines.
Preceding the assurance activities in the Philippines, Bureau Veritas conducted the following activities: • completed a Gap Analysis of the WHO Code and EO51 and the RIRR to consider where the scope of local legislation differed from the WHO Code;
• requested a list of Nestlé Philippines employees, healthcare facilities and healthcare professionals and distributors from Nestlé Philippines;
• identified other external stakeholders (through the Bureau Veritas representatives in the
Philippines) and local NGOs concerned with the protection, promotion and support of breastfeeding; and,
• independently determined a schedule of interviews to take place in the Philippines between
11 and 22 August 2010. All external stakeholder interviews were arranged by Bureau Veritas.
During the assurance Bureau Veritas:
• undertook 71 interviews with a comprehensive range of key external stakeholders
(Government officials,
Introduction
Bureau Veritas has been commissioned by Nestlé S.A. to provide independent assurance of Nestlé
Philippines compliance with the World Health Organisation (WHO) International Code of Marketing of
Breast Milk Substitutes (1981) and subsequent World Health Assembly (WHA) resolutions (herein known as the WHO Code) and the Philippines Executive Order No. 51 1986, National Code of
Marketing of Breastmilk Substitutes, Breastmilk Supplements and other related products (herein known as EO51), and the Revised Implementing Rules and Regulations 2006 (herein known as
RIRR). This follows similar work previously conducted by Bureau Veritas for Nestlé SA in other global operations. Scope of Work and Methodology
The assurance was conducted in the Philippines between 11 and 22 October 2010 by two assessors from Bureau Veritas UK Limited. The team has extensive experience of undertaking WHO Code compliance related work and was supported by two representatives of Bureau Veritas Philippines.
Preceding the assurance activities in the Philippines, Bureau Veritas conducted the following activities: • completed a Gap Analysis of the WHO Code and EO51 and the RIRR to consider where the scope of local legislation differed from the WHO Code;
• requested a list of Nestlé Philippines employees, healthcare facilities and healthcare professionals and distributors from Nestlé Philippines;
• identified other external stakeholders (through the Bureau Veritas representatives in the
Philippines) and local NGOs concerned with the protection, promotion and support of breastfeeding; and,
• independently determined a schedule of interviews to take place in the Philippines between
11 and 22 August 2010. All external stakeholder interviews were arranged by Bureau Veritas.
During the assurance Bureau Veritas:
• undertook 71 interviews with a comprehensive range of key external stakeholders
(Government officials,